Nishant Pant breaks down a trade in consulting stock Accenture.
Category: Uncategorized
Eli Lilly shares could be set for a big move if the Zepbound maker adds to its winning streak
The pharmaceuticals giant has exceeded Wall Street’s expectations for five straight quarters, helped by the success of its GLP-1 drugs for obesity.
Citi calls these smaller stocks buys that are expected to rally from here
Attractive valuations and a narrowing expected earnings growth gap are two justifications for the continued rotation into smaller names, Citi said.
Here are Tuesday’s biggest analyst calls of the day: Apple, Netflix, Tesla, Meta, Uber, Amazon, Walmart, First Solar & more
Here are the biggest calls on Wall Street on Tuesday.
This little-known medical technology stock can rally more than 40%, Jefferies says
Jefferies is seeing a clearer outlook for shares of this maker of ocular implants
Buy this advertising tech stock poised to rally more than 25%, Wells Fargo says
It’s time for investors to consider scooping up shares of this advertising technology stock as it captures more advertising spending, Wells Fargo says.
Tuesday’s big stock stories: What’s likely to move the market in the next trading session
The 30-stock Dow jumped more than 270 points to snap a five-day losing streak on Monday as oil prices dipped. Here’s what CNBC is watching going into Tuesday.
These stocks reporting this week, including Snap, are poised to see wild earnings moves
Earnings season is in full swing, and some names reporting this week are positioned for major moves.
How to position fixed-income portfolios for a Trump or Harris win, according to RBC
The election outcome could have a big impact on fixed income, says RBC Global Asset Management.
Beware McDonald’s, but these other restaurant stocks look attractive, says Katie Stockton
The chart analyst breaks down the chart in McDonald’s and a few other stocks.